Hims & Hers has absolutely exploded over the last few years (expected 2023 revenue: $800mn+). Before and after its IPO in 2021, it's generated massive amounts of data as it's evolved into a multispecialty telehealth platform that connects consumers to medical care for numerous conditions related to mental health, sexual health, dermatology and primary care. One of it's newer programs? An AI-powered clinical decision making tool to treatments for some mental health conditions - another area of potential growth. (November 2023)